JUNE 2018
Hot Topics!
HIRN Annual Executive Summary

The HIRN Year 3 Annual Executive Summary Report has been published. We welcome you to download a copy and learn more about the goals, accomplishments, and scientific breakthroughs of the Human Islet Research Network.
The Human Pancreas Analysis Program (HPAP) is performing deep phenotyping of the human endocrine pancreas and its interactions with the immune system. The primary goal is to accumulate, analyze and distribute high value T1D datasets to the diabetes research community. Data from specimens in this database are accessible on the HPAP website.

Register for a HPAP database account to gain access to the data. Refer to the instruction guide on how to navigate the website.

For additional information on how to navigate the HPAP website please view the overview poster on the HPAP News and Publications web page.
An update to the HIRN Resource Browser (v2.1) was completed on May 4 th . The HIRN Resource Browser is an online tool that investigators can use to search for Bioreagents, Datasets, Documents, and Technologies generated and/or used by HIRN. The catalog currently has 505 resources. The update adds additional curated content, enables exports of data in JSON, RDF/XML, and allows querying of information using a SPARQL endpoint. This change was undertaken to improve the rigor and reproducibility of HIRN data, by utilizing FAIR principles to facilitate knowledge transfer and discovery. 
Job Opportunity
The National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), at the National Institutes of Health (NIH) is seeking an exceptional investigator to serve as the Director, Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) . Interested candidates should submit a CV and cover letter, that addresses a vision and qualifications, to Camila Torrella by Ju ne 1 5, 2018.  For more information please view NIH NIDDK Job Opportunities website or view the job announcement .
Funding Opportunities
NIH Requests for Applications (RFAs)

RFA-RM-18-011 Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
  • The NIH Common Fund intends to commit $2M to fund 5-6 awards in FY 2019
  • Letter of Intent due: June 9, 2018
  • Application due: July 9, 2019

RFA-DK-18-005: Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed)
  • NIDDK intends to commit $3.25 million in FY 2019 to fund 4-5 awards
  • Letter of Intent due: November 6, 2018
  • Application due: December 6, 2018

Please check the NIH NIDDK website for additional Special Diabetes Funding Program Opportunities
The HIRN Projects Webpage provides project abstracts along with a listing of the project publications.
As a reminder please cite your HIRN grant accordingly in publications:
"This research was performed using resources and/or funding provided by the NIDDK-supported Human Islet Research Network (HIRN, RRID:SCR_014393; https://hirnetwork.org ; UC4 DKZZZZ to XY)."
Upcoming Meetings
Metabolomics 2018 Conference

The 14 th   Internati onal Conference of the Metabolomics Society will be on June 24-28 at the Washington State Convention Center in Seattle, WA
78 th ADA Scientific Sessions

The 78 th American Diabetes Association Scientific Sessions will be held on June 22-26 in Orlando, Florida.